Earnings Feed
Start Free
$VIRX·4

SUNESIS PHARMACEUTICALS INC · Jul 21, 4:58 PM ET

SUNESIS PHARMACEUTICALS INC 4

4 · SUNESIS PHARMACEUTICALS INC · Filed Jul 21, 2009

Insider Transaction Report

Form 4Exit
Period: 2009-07-17
SUNESIS PHARMACEUTICALS INCSNSS
WARBURG PINCUS EQUITY PARTNERS LP
10% Owner
Transactions
  • Sale

    Common Stock, par value $0.0001 per share

    [F1][F2]
    2009-07-17$0.30/sh−7,625$2,308→ 3,661,930 total
  • Sale

    Common Stock, par value $0.0001 per share

    [F3][F2]
    2009-07-20$0.28/sh−110,200$30,933→ 3,551,730 total
  • Sale

    Common Stock, par value $0.0001 per share

    [F4][F2]
    2009-07-21$0.28/sh−347,655$95,709→ 3,204,075 total
Holdings

  • Common Stock Warrant

    [F2]
    Exercise: $6.21From: 2006-03-17Exp: 2013-03-17→ Common Stock, par value $0.0001 per share (241,546 underlying)
    241,546
Footnotes (4)
  • [F1]See Exhibit 99.1
  • [F2]See Exhibit 99.1
  • [F3]See Exhibit 99.1
  • [F4]See Exhibit 99.1
Signature
WARBURG, PINCUS EQUITY PARTNERS, L.P. By: Warburg Pincus Partners, LLC, its General Partner, By: Warburg Pincus & Co., its Managing Member, By: /s/ Scott A. Arenare, Partner|2009-07-21

Documents

4 files